Cascade Technologies, Inc. (CSDT.OB) Subsidiary Briefs Investors Regarding Development of Advanced Devices for Cancer Detection and Other Applications
Friday, Spectral Molecular Imaging (SMI), a wholly-owned subsidiary of Cascade Technologies, Inc., announced the availability of a new Investor Information Brief outlining the company’s proprietary technology and its strategy to develop a line of optical imaging devices for earlier detection of cancer and other major disease. The subsidiary is applying proprietary high-resolution optical imaging technology to develop an assortment of imaging devices designed for the purpose of detecting major disease and assessing the health of tissues during and after surgery. The technology was originally developed for use in satellite reconnaissance. The Company’s hyperspectral imaging technology is designed to enable the…